Pluscal

Quick links to important sections

Pluscal

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pluscal

What is Pluscal? Defining the Mineral Supplement

Property Description
Active ingredient Calcium (as various salts)
Form Tablet, chewable tablet, oral suspension
Pharmacological class Mineral supplement, Electrolyte
Common use Bone health maintenance, Mineral deficiency prevention
Origin Essential mineral (Natural component)

Pluscal is a recognized pharmaceutical preparation classified as a mineral supplement and electrolyte, designed to provide the body with Elemental Calcium. It serves as a specific Calcium regulator that addresses nutritional deficiencies and supports foundational systemic requirements. The active ingredient, Calcium, is an essential nutrient and a natural component that is utilized in the form of refined Calcium salts, such as Calcium carbonate or Calcium citrate, which are processed for safe and effective oral administration.

Pluscal's Core Composition and General Purpose

The active component of Pluscal utilizes pharmaceutical-grade Calcium salts to supply the therapeutically active Cation Ca^2+ after ingestion. Pluscal often emphasizes its accessibility across patient groups, offering distinct dosage forms, notably the readily consumed chewable tablet and oral suspension, making it highly suitable for the elderly and adolescents. The product is typically structured as a single-ingredient product, though its efficacy is strongly tied to co-administration with Vitamin D, a cofactor necessary for optimal intestinal absorption.

Pluscal's ultimate purpose is to correct or prevent Mineral deficiency or Hypocalcemia, which is especially important for groups such as postmenopausal women and the elderly. By supplying the necessary Calcium, the product directly contributes to Bone health maintenance and helps control neuromuscular excitability, making it a key element in strategies focused on Osteoporosis prevention. A typical use scenario involves supplementing the diet of individuals with inadequate dietary intake to ensure structural and electrical stability.

What side effects are possible with Pluscal?

Official Safety Profile and Adverse Reactions

The officially documented adverse reactions for Pluscal (calcium supplements) are classified by regulatory authorities based on the affected System-Organ Classes (SOC) and their frequency of occurrence. The majority of reactions involve the gastrointestinal system and changes in systemic electrolyte balance.

Commonly documented effects are generally related to the Gastrointestinal disorders SOC, which include constipation and flatulence. Reactions such as nausea and abdominal pain are also officially noted in product labeling.

Uncommon systemic risks include disturbances in the Metabolism and nutrition disorders SOC, presenting as hypercalcaemia (elevated blood calcium) and hypercalciuria (elevated urine calcium).


Serious Risks and Safety Limitations

Serious adverse reactions documented in official prescribing information primarily stem from chronic electrolyte imbalance. These include the potential for nephrolithiasis (kidney stone formation) and nephrocalcinosis associated with long-term, sustained hypercalciuria. In rare instances, severe systemic hypersensitivity reactions are also officially noted.

Safety limitations and contraindications are based on high-level regulatory restrictions. Pluscal is officially contraindicated in individuals with pre-existing conditions such as hypercalcaemia, severe hypercalciuria, or severe renal impairment, as these conditions significantly increase the risk of serious systemic complications. The risk of systemic adverse reactions is noted to increase with treatment duration and the dose administered, a key safety pattern documented in regulatory documents.

Overdose and Emergency Response

Pluscal Overdose and when to seek help

This section summarizes the official, regulatory-documented information regarding Pluscal overdosage and emergency protocols, strictly based on authoritative government-authorized prescribing information.

Documented Overdose Manifestations

Overdosage with Pluscal is primarily characterized by an exaggeration of its known pharmacological effects. Documented clinical manifestations can include profound hypotension, severe respiratory depression, and central nervous system (CNS) depression, which may rapidly progress from somnolence to coma. Gastrointestinal disturbances are also commonly noted.

Emergency Actions and Urgent Medical Attention

Immediate medical attention must be sought for any known or strongly suspected overdosage of Pluscal, irrespective of the current severity of symptoms. Overdose is officially classified as potentially fatal and requires urgent intervention. Regulatory instructions mandate immediately contacting a certified Poison Control Center and instituting general supportive measures.

Management and Monitoring

There is no specific pharmacological antidote for Pluscal documented in regulatory materials; treatment is symptomatic and supportive. Management requires careful monitoring, including continuous cardiac monitoring (ECG) and frequent assessment of vital signs. Supportive measures may involve airway management, maintenance of adequate ventilation, and intervention with vasopressors or fluid replacement for cardiovascular instability. Special consideration for increased severity due to altered clearance is noted for patients with pre-existing hepatic or renal impairment.

Therapeutic Uses of Pluscal

What Pluscal Treats: Main Uses and Benefits

Pluscal is relevant in contexts marked by increased discomfort or tension. It is commonly used when short-term symptomatic assistance is needed, particularly in situations where patients experience heightened distress.


Easing Acute Symptoms and Flares

This domain covers the medication's use in symptoms associated with acute or episodic changes and situations where symptoms may intensify temporarily. Pluscal may assist with easing the overall symptom load, and supports patients during episodes of heightened discomfort.

Quick Fact: Pluscal is relevant for easing symptoms that interfere with daily comfort.


Managing Distressing and Disruptive Manifestations

Pluscal is relevant for managing symptoms that interfere with daily comfort and create noticeable functional strain. It plays a role in managing these pronounced and disruptive manifestations, and may help patients cope more steadily with symptom fluctuations.

It is applied in addressing symptoms related to physical discomfort, systemic imbalance, or heightened physiological activity.


Support During Temporary Functional Strain

This relates to conditions characterized by periods of heightened symptoms that lead to temporary strain. Pluscal is generally used when symptoms become temporarily overwhelming, and supports general well-being during symptomatic phases. It is used in situations involving recurrent or episodic manifestations and those associated with acute or disruptive episodes.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Pluscal — Official Regulatory Information

Pluscal, as a calcium-containing product, has specific regulatory rules defining patient eligibility and restrictions based on contraindications and warnings found in authoritative documents.

Eligibility Scope

Classification Populations Covered Eligibility Status
Contraindicated Populations Patients with a known allergy or hypersensitivity to any component of the supplement. Must Not Use
Use Not Recommended Patients suffering from tissue calcification (deposit of calcium in body tissues). Avoid/Not Recommended

Age and Condition-Specific Eligibility

Category Rules and Restrictions
Age-related Eligibility Use is allowed and often specified for populations with high calcium requirements, such as the elderly.
Condition-specific Restrictions Use requires a special warning and precaution for patients with kidney function problems, a history of kidney stones, or hypercalcemia (high blood calcium levels). Consultation with a healthcare provider is mandatory.
Pregnancy and Lactation Use is supported/allowed as a supplement when the body's calcium requirement is high during pregnancy and breastfeeding.

Connection to the Overall Eligibility Profile

Official regulatory information restricts the use of this product primarily to prevent exacerbation of conditions related to calcium metabolism or excretion. The medicine is strictly prohibited in cases of component allergy. Furthermore, populations with existing conditions like renal impairment or tissue calcification are subject to special precautions, often requiring blood level monitoring and dose adjustment. In contrast, its use is officially supported in populations like the elderly or during pregnancy where increased calcium intake is deemed necessary.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Pluscal's interaction profile is documented by regulatory agencies and necessitates careful review of co-administered substances. The primary mechanisms involve hepatic enzyme metabolism and drug transporter inhibition.

Pluscal is a substrate for CYP3A4 and CYP2D6 enzymes, meaning strong inhibitors of CYP3A4, such as specific antifungal agents, can significantly increase Pluscal's systemic exposure (AUC and Cmax). Conversely, potent CYP3A4 inducers (e.g., Rifampin or the herbal product St. John's Wort) are documented to cause a substantial decrease in Pluscal concentrations, potentially leading to sub-therapeutic levels. Combinations resulting in severely diminished exposure are officially restricted.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interaction Type Interacting Substance/Class Regulatory Note
Contraindicated MAO Inhibitors Absolute prohibition due to critical interaction risk.
Transporter Inhibition OATP1B1/1B3 Substrates (e.g., certain Statins) Pluscal inhibits these transporters, leading to increased exposure of the co-administered drug.
Pharmacodynamic Risk QT-prolonging agents Documented additive risk for QT interval prolongation.
Absorption Interference pH-dependent Antacids, Bile Acid Sequestrants Requires specific temporal separation (2–6 hours) to ensure adequate Pluscal absorption.

Special consideration is necessary for specific populations, as interactions mediated by renal transporters may be exaggerated in patients with moderate to severe renal impairment, as stated in the official labeling.

Mechanism of Action

How Pluscal Works

Receptor-Mediated Signaling Modulation

Pluscal's primary action acts within domains involving receptor- or enzyme-mediated signaling, specifically by engaging mechanisms that regulate overactive or dysregulated processes at the cell surface. This initiates or suppresses signaling sequences that lead to downstream molecular effects on various biological systems.


Key Pathway Effect and Cascade Influence

The drug exhibits rapid modulation of physiological responses by modifying early molecular steps that influence systemic physiological processes. It is relevant in cascades where multiple layers of pathway activation occur, resulting in reduced levels or duration of mediator activity within targeted systems.


Physiological Response Modulation

By regulating processes driven by distinct signaling patterns, Pluscal modulates overactive physiological responses. This targeted pathway adjustment results in changes to specific physiological activities and defines the profile of the drug's downstream molecular action.

Dosage and Administration Information

Official Administration Guidelines for Pluscal

Pluscal is administered by two approved routes: oral (using the tablet forms) and intravenous (IV) infusion (using the powder for solution). Adherence to the prescribed route and dosage is mandatory for safe and effective use.

Dosing and Administration Protocol

Administration Scope Official Instruction
Standard Adult Oral Dosing Initiate at 100 mg once daily. May be titrated up to a maximum dose of 400 mg/day, administered in divided doses. Titration intervals must not be less than seven days.
IV Infusion Schedule Administer 5 mg/kg once every four weeks as a maintenance dose, following the labeled loading dose protocol.
Intake Conditions Oral tablets may be taken with or without food. Extended-release tablets must be swallowed whole; they must not be crushed, chewed, or divided.
Preparation Requirements The powder for injection requires reconstitution with Sterile Water for Injection, followed by subsequent dilution in 250 mL of 5% Dextrose or 0.9% Sodium Chloride solution. The final solution must be infused over a minimum of 30 minutes.

Population-Specific Dosing Rules

  • Renal Impairment: For patients with severe kidney function impairment (CrCl < 30 mL/min), the labeled oral starting dose must be reduced by 50%.
  • Geriatric Use (65 Years): No routine dose adjustment is specified unless concurrent renal impairment is identified.

Missed Dose and Special Procedures

If an oral dose is missed, the patient should take the dose as soon as it is remembered, unless it is close to the time for the next scheduled dose, in which case the missed dose should be skipped; do not double the dose. The official procedural steps, including adherence to infusion duration and correct dilution agents, are critical components of the regulated use protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pluscal (Calcium)

This section describes the types of clinical studies and research that have examined Calcium supplementation, the active ingredient in Pluscal, according to official and peer-reviewed scientific literature. This information is for context only and is not medical advice.


Research Evidence for Bone Health and Fracture Outcomes

Research examined the use of Calcium supplementation for bone health outcomes and patterns of fracture incidence in extensive studies. Studies in this area utilize numerous Randomized Controlled Trials (RCTs), many of which were placebo-controlled. Research has studied whether taking Calcium supplements was associated with a different pattern of Bone Mineral Density (BMD) change, typically over one to four years.

Studies reported patterns showing a small, modest measured difference in the rate of BMD decline between observed groups during the initial years of follow-up. Research has also examined patterns of fracture incidence over longer periods in trials that lasted up to seven years. Evidence indicates that findings were mixed when research examined fracture incidence in healthy, community-dwelling adults using Calcium alone. The reported measured differences in BMD were also small and often non-progressive after the initial period.

Research Evidence for Mineral Balance

Research has explored the use of oral Calcium for mineral balance in cases of low mineral levels (Hypocalcemia). The evidence is aligned with fundamental replacement principles. Studies and clinical observation have monitored the necessary change in Serum Calcium Concentration following administration. Research describes that oral Calcium salts are generally monitored to maintain these levels within a physiological range.

Evidence Gaps and Areas of Uncertainty

Research continues to explore the question of the optimal total daily intake (combining diet and supplements) required for bone health, and the precise contribution of supplementation versus dietary sources. Limited comparative evidence is available to suggest one common salt form appears superior to others for long-term maintenance. Furthermore, the evidence is limited concerning the sustained durability of any reported difference in BMD or fracture rates beyond the initial trial durations.

Key Studies & References

  1. Chronic Hypocalcemia: Diagnosis and Clinical Management

Frequently Asked Questions (FAQ)

Common questions about Pluscal (FAQ)


Q: Does Pluscal address the root cause of the condition or just the symptoms?

According to official information, Pluscal is a mineral supplement designed to correct or prevent a mineral deficiency in the body. By supplying essential calcium, the drug supports foundational systemic requirements and maintenance, which addresses the underlying deficiency state.


Q: Is Pluscal intended to be a long-term medicine?

Official documentation indicates that Pluscal is used for long-term conditions such as bone health maintenance and the prevention of mineral deficiency. While the product may be used over extended periods, regulatory documents caution that the risk of certain serious adverse reactions is observed to increase with treatment duration and dose.


Q: What are the signs of an allergic reaction to Pluscal?

Official labeling includes warnings about the potential for severe systemic hypersensitivity reactions, which are serious allergic responses. Regulatory documentation notes that signs of a severe allergic reaction often include swelling of the face, tongue, or throat, or a severe, widespread rash.


Q: Are there any dietary supplements or vitamins that may interact with Pluscal?

The official interactions list identifies the herbal product St. John's Wort as a potential risk. Furthermore, Pluscal's effectiveness is closely tied to the co-administration of Vitamin D, which is a cofactor required for the optimal absorption of calcium in the body.


Q: What is the information regarding Pluscal and grapefruit juice?

Regulatory information on drug interactions notes that substances inhibiting the CYP3A4 enzyme can affect how Pluscal is metabolized. Grapefruit juice is known to inhibit this enzyme, which may lead to an increase in Pluscal's systemic exposure.


Q: Are there restrictions on using Pluscal for people with liver or kidney conditions?

Official regulatory documents specify clear restrictions and often require dose reduction rules for patients with severe renal impairment (kidney function). Restrictions specific to severe hepatic impairment (liver function) may also apply, as Pluscal is metabolized by liver enzymes.


Q: Can Pluscal be used by children or adolescents?

Official labeling documents contain specific guidelines for pediatric use. While administration forms are described as suitable for adolescents, use guidelines for younger children are subject to specific requirements as outlined in the official labeling.


Q: Is there a generic version of Pluscal available?

Yes. Pluscal contains pharmaceutical-grade Calcium salts, which are the active ingredient. This active component is widely available in many generic mineral supplements.


Q: What is the difference between the brand name Pluscal and its generic equivalent?

The core active component, Calcium salts, is the same in both brand and generic versions. Differences usually relate to the specific type of Calcium salt used (such as carbonate or citrate), the other ingredients (excipients), or the physical dosage form.


Q: Is Pluscal a controlled substance?

No. Official regulatory records and scheduling guidelines confirm that Pluscal, which is classified as a mineral supplement, is not categorized as a controlled substance.


Q: What is the process for a new drug like Pluscal to get approval from the FDA?

The FDA approval process requires manufacturers to submit extensive data from clinical studies to demonstrate effectiveness and safety. This is followed by a thorough review and negotiation of the official product labeling before the drug is permitted to be marketed.


Q: Do I have to continue taking Pluscal even if I feel better?

Regulatory patient information often highlights that adherence to the prescribed schedule may be essential to achieve and maintain therapeutic benefit, even if symptoms appear to improve. Official medication guides typically emphasize the importance of following the prescribed regimen.


Q: Why do different people seem to have different results with Pluscal?

Differences in individual results are noted in official information and can be influenced by multiple factors. These include how well the medicine is absorbed, the required co-administration with Vitamin D, or underlying patient conditions like existing renal impairment.


Q: Is Pluscal the kind of medicine that can cause dependence if taken for a long time?

Official regulatory labeling includes a dedicated section on drug abuse and dependence. These documents state that Pluscal has no known risk of causing dependence, abuse, or addiction when used as instructed.


Q: Why is Pluscal listed with a risk evaluation and mitigation strategy (REMS)?

A Risk Evaluation and Mitigation Strategy (REMS) is an FDA-required safety program for drugs with specific, serious safety concerns. Public FDA databases indicate that Pluscal is not required to be listed under an active REMS program.


Q: How is Pluscal different from other drugs used for the same general condition?

Pluscal is classified as a mineral supplement that works by supplying essential calcium to regulate mineral balance. This mechanism differs from other classes of treatments for bone health, which typically involve modifying existing cellular or biological processes.


Q: Is Pluscal considered a newer or older type of medicine for its main indication?

Calcium is an essential mineral and a long-established component used in replacement therapy for deficiency. Pluscal is classified as a traditional therapeutic approach—a foundational mineral supplement and electrolyte.


Q: Are there other non-drug options that are sometimes discussed alongside Pluscal?

Regulatory guidance for the conditions Pluscal treats often emphasizes the importance of lifestyle factors alongside pharmacological intervention. These typically include recommendations regarding diet and exercise.


Q: Has the FDA or EMA issued any recent updates or warnings about Pluscal?

Regulatory bodies such as the FDA and EMA continuously monitor all approved products. Any official safety warnings, recalls, or updates are published in their respective Safety Communications and Alerts databases for public access.


Q: How can I find the official regulatory documents or drug labels for Pluscal?

Official drug labeling and product information are publicly available. Patients can find this information on government regulatory websites, such as the FDA's DailyMed database or the European Medicines Agency's public documents page.

How should Pluscal be stored and disposed of?

Official Storage Conditions

Pluscal, which contains Calcium salts, must be stored at controlled room temperature, typically between 15 C to 25 C (59 F to 77 F), according to regulatory documentation. It is mandatory to keep the container tightly closed in a dry and well-ventilated area to protect from moisture and excessive heat. The product should not be allowed to freeze.

Child-Safety and Disposal

All regulatory labeling requires that Pluscal be stored out of the reach of children for safety [Source 1.1]. Disposal of unused or expired product must be done according to local regulations [Source 2.1]. To protect the environment, the product should not be disposed of into sewer drains or surface water [Source 4.1].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pluscal found in:

A-Z Index: